Matinas BioPharma Holdings, Inc. (MTNB)
NYSEAMERICAN: MTNB · Real-Time Price · USD
0.642
+0.020 (3.15%)
Jun 26, 2026, 4:00 PM EDT - Market closed
MTNB Employees
Matinas BioPharma Holdings had 2 employees as of December 31, 2025. The number of employees decreased by 1 or -33.33% compared to the previous year.
Employees
2
Change (1Y)
-1
Growth (1Y)
-33.33%
Revenue / Employee
n/a
Profits / Employee
-$5,614,000
Market Cap
4.12M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Evogene | 52 |
| FibroBiologics | 15 |
| TransCode Therapeutics | 12 |
| Ensysce Biosciences | 10 |
| Revelation Biosciences | 9 |
| Artelo Biosciences | 7 |
| Galmed Pharmaceuticals | 6 |
| 60 Degrees Pharmaceuticals | 3 |
MTNB News
- 1 day ago - Matinas BioPharma receives noncompliance notification from NYSE - TheFly
- 1 day ago - Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards and Acceptance of Plan to Regain Compliance - GlobeNewsWire
- 11 days ago - Matinas BioPharma files $150M mixed securities shelf - TheFly
- 11 days ago - Matinas BioPharma Holdings Registration statement: Registration filing - Filings
- 7 weeks ago - Matinas BioPharma Holdings Quarterly report: Q1 2026 - Filings
- 3 months ago - Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards - GlobeNewsWire
- 3 months ago - Matinas BioPharma Holdings Annual report: Q4 2025 - Filings
- 8 months ago - Matinas BioPharma Holdings Quarterly report: Q3 2025 - Filings